Trials / Withdrawn
WithdrawnNCT01656616
Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- MaineHealth · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyanide antidote administration |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-08-03
- Last updated
- 2017-05-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01656616. Inclusion in this directory is not an endorsement.